Concentrix Corporation
CNXC
$37.35
-$0.91-2.38%
NASDAQ
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.83B | 9.72B | 9.63B | 9.59B | 9.62B |
| Total Other Revenue | -- | 572.62M | 1.15B | 1.75B | 2.33B |
| Total Revenue | 9.83B | 9.72B | 9.63B | 9.59B | 9.62B |
| Cost of Revenue | 6.39B | 6.29B | 6.19B | 6.14B | 6.17B |
| Gross Profit | 3.44B | 3.43B | 3.44B | 3.45B | 3.45B |
| SG&A Expenses | 2.50B | 2.54B | 2.52B | 2.51B | 2.52B |
| Depreciation & Amortization | 328.71M | 331.04M | 335.81M | 342.62M | 342.62M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.22B | 9.16B | 9.04B | 8.99B | 9.03B |
| Operating Income | 605.27M | 558.72M | 583.16M | 599.29M | 589.32M |
| Income Before Tax | -1.18B | 376.86M | 291.84M | 327.24M | 299.27M |
| Income Tax Expenses | 96.70M | 60.75M | 47.20M | 57.87M | 48.06M |
| Earnings from Continuing Operations | -1.28K | 316.11 | 244.63 | 269.37 | 251.22 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.28B | 316.11M | 244.63M | 269.37M | 251.22M |
| EBIT | 605.27M | 558.72M | 583.16M | 599.29M | 589.32M |
| EBITDA | 1.27B | 1.22B | 1.25B | 1.28B | 1.30B |
| EPS Basic | -20.73 | 4.74 | 3.65 | 4.00 | 3.72 |
| Normalized Basic EPS | 3.40 | 3.15 | 2.58 | 2.89 | 2.59 |
| EPS Diluted | -20.73 | 4.74 | 3.65 | 4.00 | 3.72 |
| Normalized Diluted EPS | 3.39 | 3.15 | 2.58 | 2.89 | 2.58 |
| Average Basic Shares Outstanding | 252.06M | 254.31M | 256.37M | 258.28M | 259.91M |
| Average Diluted Shares Outstanding | 252.24M | 254.53M | 256.57M | 258.50M | 260.23M |
| Dividend Per Share | 1.36 | 1.33 | 1.30 | 1.27 | 1.24 |
| Payout Ratio | -7.01% | 28.16% | 35.72% | 31.77% | 33.36% |